SCIENTIFIC BACKGROUND

ATP1A2, CACNA1A, SCN1A

Familial Hemiplegic Migraine (FHM) is a rare (prevalence approximately 1:10,000) monogenic form of migraine. Since 2004, the criteria of the International Headache Society have included FHM with forms of migraine with aura. The aura can include visual, sensory and speech disorders, but FHM is accompanied by a motor disorder in the form of reversible hemiparesis, which can last longer. In 20-40% of families, additional cerebellar symptoms such as progressive mild ataxia and/or nystagmus have been reported. By definition, the familial form requires at least one other first-degree relative with the disease.

 

The aura is presumably caused by CSD (cortical spreading depression), a depression wave that spreads slowly through the cerebral cortex and temporarily inhibits other neuronal activity. The actual headache is said to be caused by an activation of the so-called trigeminal vascular system (TGVS). Therapeutically and prophylactically, drugs can be used in the same way as for migraine. Triptans and other vasoconstrictive substances should be avoided.

 

So far, pathogenic variants associated with familial hemiplegic migraine have been identified in three genes. These genes (CACNA1A, ATP1A2 and SCN1A) encode either components of ion channels (CACNA1A and SCN1A) or a Na+-K+-ATPase (ATP1A2). Thus, FHM belongs to the group of ion channel diseases. Since pathogenic variants in these genes have not been detected in all families, it is suspected that there exist other rarer forms (FHM4-6). The sporadic form (SHM) is explained by dominant new mutations or reduced penetrance. Depending on the population studied, either no or only very rarely were pathogenic variants identified in the known FHM-causing genes in SHM. Since the forms do not differ much clinically, the molecular genetic clarification of these three genes using next generation sequencing (NGS) allows the investigation of the three genes in one sequence run.

 

FHM shows clinical, genetic and pathophysiological overlaps with epilepsy and other neurological diseases. Pathogenic variants in the three genes have also been described as the cause of epilepsy, for example, the SCN1A gene as the cause of Dravet syndrome or generalized epilepsy with febrile seizures plus (GEFS+). Due to autosomal dominant inheritance, there is a 50% risk of recurrence for offspring of carriers of pathogenic variants.

 

References

Pelzer et al. 2018, Neurology 90:e575 / Huang et al. 2017, Neuropsychiatr Dis Treat 13:1175 / Zameel Cader 2013, Hum Mol Genet Oct 15;22(R1):R39-44 / Di Lorenzo et al. 2012, J Headache Pain 13:571 / Weir et al. 2011, BMC Med 9:16 / Russel 2011, Lancet Neurol 10, 5:457 / Pietrobon 2010, J Physiol 588.11:1871 / de Vries et al. 2009, Hum Genet 126:115 / Haan et al. 2007, Cephalalgia 28:105 / Kubisch 2007, Med Gen 19:330

GENES

ATP1A2, CACNA1A, SCN1A

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of...

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni...

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more